Safety and activity of temsirolimus and bevacizumab in patients with advanced renal cell carcinoma previously treated with tyrosine kinase inhibitors: A phase 2 consortium study

Jaime R. Merchan, Rui Qin, Henry Pitot, Joel Picus, Glenn Liu, Tom Fitch, William J. Maples, Patrick J. Flynn, Briant F. Fruth, Charles Erlichman

Research output: Contribution to journalArticle

14 Scopus citations

Fingerprint Dive into the research topics of 'Safety and activity of temsirolimus and bevacizumab in patients with advanced renal cell carcinoma previously treated with tyrosine kinase inhibitors: A phase 2 consortium study'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds